Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Prognostic significance of YWHAZ expression in localized prostate cancer.

Rüenauver K, Menon R, Svensson MA, Carlsson J, Vogel W, Andrén O, Nowak M, Perner S.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):310-4. doi: 10.1038/pcan.2014.32. Epub 2014 Aug 26.

PMID:
25156059
[PubMed - in process]
2.

Limited evidence for the use of imaging to detect prostate cancer: a systematic review.

Blomqvist L, Carlsson S, Gjertsson P, Heintz E, Hultcrantz M, Mejare I, Andrén O.

Eur J Radiol. 2014 Sep;83(9):1601-6. doi: 10.1016/j.ejrad.2014.06.028. Epub 2014 Jul 5.

PMID:
25059597
[PubMed - in process]
3.

Analysis of incidence and prognosis from 'extreme' case-control designs.

Salim A, Ma X, Fall K, Andrén O, Reilly M.

Stat Med. 2014 Jul 1. doi: 10.1002/sim.6245. [Epub ahead of print]

PMID:
24980445
[PubMed - as supplied by publisher]
4.

MED12 overexpression is a frequent event in castration-resistant prostate cancer.

Shaikhibrahim Z, Offermann A, Braun M, Menon R, Syring I, Nowak M, Halbach R, Vogel W, Ruiz C, Zellweger T, Rentsch CA, Svensson M, Andren O, Bubendorf L, Biskup S, Duensing S, Kirfel J, Perner S.

Endocr Relat Cancer. 2014 Aug;21(4):663-75. doi: 10.1530/ERC-14-0171. Epub 2014 Jun 17.

PMID:
24938407
[PubMed - in process]
5.

Radical prostatectomy or watchful waiting in early prostate cancer.

Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE.

N Engl J Med. 2014 Mar 6;370(10):932-42. doi: 10.1056/NEJMoa1311593.

PMID:
24597866
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The first peripherally masked thiol dendrimers: a facile and highly efficient functionalization strategy of polyester dendrimers via one-pot xanthate deprotection/thiol-acrylate Michael addition reactions.

Auty SE, Andrén O, Malkoch M, Rannard SP.

Chem Commun (Camb). 2014 Jun 25;50(50):6574-7. doi: 10.1039/c3cc49704f.

PMID:
24595823
[PubMed - in process]
7.

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

Blattner M, Lee DJ, O'Reilly C, Park K, MacDonald TY, Khani F, Turner KR, Chiu YL, Wild PJ, Dolgalev I, Heguy A, Sboner A, Ramazangolu S, Hieronymus H, Sawyers C, Tewari AK, Moch H, Yoon GS, Known YC, Andrén O, Fall K, Demichelis F, Mosquera JM, Robinson BD, Barbieri CE, Rubin MA.

Neoplasia. 2014 Jan;16(1):14-20.

PMID:
24563616
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohort.

Svensson MA, Perner S, Ohlson AL, Day JR, Groskopf J, Kirsten R, Sollie T, Helenius G, Andersson SO, Demichelis F, Andrén O, Rubin MA.

Appl Immunohistochem Mol Morphol. 2014;22(2):136-41. doi: 10.1097/PDM.0b013e31829e0484.

PMID:
24517914
[PubMed - indexed for MEDLINE]
9.

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.

Shaikhibrahim Z, Menon R, Braun M, Offermann A, Queisser A, Boehm D, Vogel W, Rüenauver K, Ruiz C, Zellweger T, Svensson M, Andren O, Kristiansen G, Wernert N, Bubendorf L, Kirfel J, Biskup S, Perner S.

Int J Cancer. 2014 Jul 1;135(1):19-26. doi: 10.1002/ijc.28647. Epub 2013 Dec 9.

PMID:
24374838
[PubMed - indexed for MEDLINE]
10.

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.

Carlsson J, Helenius G, Karlsson MG, Andrén O, Klinga-Levan K, Olsson B.

BMC Cancer. 2013 Jul 29;13:362. doi: 10.1186/1471-2407-13-362.

PMID:
23890084
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prognostic significance of phospho-histone H3 in prostate carcinoma.

Nowak M, Svensson MA, Carlsson J, Vogel W, Kebschull M, Wernert N, Kristiansen G, Andrén O, Braun M, Perner S.

World J Urol. 2014 Jun;32(3):703-7. doi: 10.1007/s00345-013-1135-y. Epub 2013 Jul 26.

PMID:
23887713
[PubMed - in process]
12.

Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study.

Wilson KM, Bälter K, Möller E, Adami HO, Andrén O, Andersson SO, Grönberg H, Mucci LA.

Cancer Causes Control. 2013 Aug;24(8):1575-81. doi: 10.1007/s10552-013-0234-9. Epub 2013 May 24.

PMID:
23702886
[PubMed - indexed for MEDLINE]
13.

Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study.

Discacciati A, Orsini N, Andersson SO, Andrén O, Johansson JE, Mantzoros CS, Wolk A.

Ann Oncol. 2013 Jul;24(7):1912-8. doi: 10.1093/annonc/mdt105. Epub 2013 Mar 18.

PMID:
23508823
[PubMed - indexed for MEDLINE]
Free Article
14.

Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case-control study.

Möller E, Galeone C, Andersson TM, Bellocco R, Adami HO, Andrén O, Grönberg H, La Vecchia C, Mucci LA, Bälter K.

J Nutr Sci. 2013 Apr 29;2:e15. doi: 10.1017/jns.2013.2. eCollection 2013.

PMID:
25191563
[PubMed]
Free PMC Article
15.

Natural history of early, localized prostate cancer: a final report from three decades of follow-up.

Popiolek M, Rider JR, Andrén O, Andersson SO, Holmberg L, Adami HO, Johansson JE.

Eur Urol. 2013 Mar;63(3):428-35. doi: 10.1016/j.eururo.2012.10.002. Epub 2012 Oct 13.

PMID:
23084329
[PubMed - indexed for MEDLINE]
16.

CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer.

Davidsson S, Ohlson AL, Andersson SO, Fall K, Meisner A, Fiorentino M, Andrén O, Rider JR.

Mod Pathol. 2013 Mar;26(3):448-55. doi: 10.1038/modpathol.2012.164. Epub 2012 Oct 5.

PMID:
23041830
[PubMed - indexed for MEDLINE]
Free Article
17.

Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer.

Lehmann S, Bykov VJ, Ali D, Andrén O, Cherif H, Tidefelt U, Uggla B, Yachnin J, Juliusson G, Moshfegh A, Paul C, Wiman KG, Andersson PO.

J Clin Oncol. 2012 Oct 10;30(29):3633-9. doi: 10.1200/JCO.2011.40.7783. Epub 2012 Sep 10.

PMID:
22965953
[PubMed - indexed for MEDLINE]
Free Article
18.

Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates.

Olsson J, Davidsson S, Unemo M, Mölling P, Andersson SO, Andrén O, Söderquist B, Sellin M, Elgh F.

APMIS. 2012 Oct;120(10):778-85. doi: 10.1111/j.1600-0463.2012.02905.x. Epub 2012 Apr 28.

PMID:
22958285
[PubMed - indexed for MEDLINE]
19.

Dynamic sentinel node biopsy in penile cancer: initial experiences at a Swedish referral centre.

Kirrander P, Andrén O, Windahl T.

BJU Int. 2013 Mar;111(3 Pt B):E48-53. doi: 10.1111/j.1464-410X.2012.11437.x. Epub 2012 Aug 29.

PMID:
22928991
[PubMed - indexed for MEDLINE]
20.

Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.

Rider JR, Sandin F, Andrén O, Wiklund P, Hugosson J, Stattin P.

Eur Urol. 2013 Jan;63(1):88-96. doi: 10.1016/j.eururo.2012.08.001. Epub 2012 Aug 10.

PMID:
22902040
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk